Skip to content
← Lobby register
EC
Trade & Business

European Confederation of Pharmaceutical Entrepreneurs

🇪🇺 BELGIUMRegistered 15/010 staff
Disclosed budget
€800,000 — €899,999
Meetings 12mo
18
Policy files
4
Accredited passes
10

Recent meetings

DateCommissioner / CabinetTopicFile
06 May 2026
Maya Matthews
Head of Unit
Exchange of views on reaching out to Small and Medium Enterprises (SMEs) under the Health Technology Assessment (HTA) RegulationSRC
11 Feb 2026
Maya Matthews
Head of Unit
Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)
11 Feb 2026
Maya Matthews
Head of Unit
Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)SRC
22 Oct 2025
Maya Matthews
Head of Unit
Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.SRC
22 Oct 2025
Maya Matthews
Head of Unit
Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.
16 Oct 2025
Laszlo Kristoffy
Cabinet member
Situation of medium sized innovative pharma sectorSRC
16 Oct 2025
Olivér Várhelyi
Commissioner
Situation of medium sized innovative pharma sector
16 Oct 2025
Olivér Várhelyi
Commissioner
Situation of medium sized innovative pharma sectorSRC
16 Oct 2025
Laszlo Kristoffy
Cabinet member
Situation of medium sized innovative pharma sector
02 Oct 2025
Jana Dabbelt
Cabinet member
All pressing portfolio topicsSRC
02 Oct 2025
Olivér Várhelyi
Commissioner
All pressing portfolio topicsSRC
02 Oct 2025
Jana Dabbelt
Cabinet member
All pressing portfolio topics
03 Jul 2025
Ann-Sofie Ronnlund
Cabinet member
Life sciencesSRC
03 Jul 2025
Ann-Sofie Ronnlund
Cabinet member
Life sciences
17 Jun 2025
Olivér Várhelyi
Commissioner
EU biotech policySRC
17 Jun 2025
Laszlo Andrejko
Cabinet member
EU biotech policy
17 Jun 2025
Laszlo Andrejko
Cabinet member
EU biotech policySRC
17 Jun 2025
Olivér Várhelyi
Commissioner
EU biotech policy
29 Apr 2025
Laszlo Andrejko
Cabinet member
Biotech
29 Apr 2025
Laszlo Andrejko
Cabinet member
BiotechSRC
27 Mar 2025
Maya Matthews
Head of Unit
EU HTA regulationSRC
27 Mar 2025
Maya Matthews
Head of Unit
EU HTA regulation
21 Nov 2024
Marc Lemaitre
Director-General
EUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industrySRC
21 Nov 2024
Marc Lemaitre
Director-General
EUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industry
18 May 2022
Giorgos Rossides
Cabinet member
Exchange of views on the upcoming reform of the pharmaceutical legislation

Mission & Goals

The European Confederation for Pharmaceutical Entrepreneurs (EUCOPE) is the voice of small to medium-sized innovative companies in the fields of pharmaceuticals, biotechnologies and medical devices. Via its member associations such as the German Pharmaceutical Industry Association (BPI), the British Ethical Medicines Industry Group (EMIG), France Biotech and the Swedish Association lif, EUCOPE represents over 2600 member companies. Corporate members include innovative family-owned companies and companies active in the field of rare diseases. EUCOPE furthers its members' scientific, technical, economic and legal objectives and represents them towards national and international governmental organisations, in particular towards the EU institutions and agencies.

EU Legislative Interests

Any legislative proposal or policy related to or affecting healthcare/public health/life sciences, in particular the general legal framework for medicinal products and medical devices as well as orphan medicinal products, substances of human origin, EU HTA and paediatrics. Industrial Strategy. Trade. The main EU legislative proposals, policies or files EUCOPE is engaged with are the below (this is not an exhaustive list): A Pharmaceutical Strategy for Europe Orphan Medicinal Products Regulation Paediatrics Regulation Directive 2001/83/EC on the Community code relating to medicinal products for human use Regulation No 726/2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency Substances of Human Origins Regulation ATMPs Regulation Clinical Trials Regulation EU Regulation on health technology assessment European Health Data Space HERA Regulation Cross-border healthcare directive Biotech Act Critical Medicines Act

Communication Activities

EUCOPE’s communication activities include: - Publishing reports on the policy areas EUCOPE is active in (e.g. reports, position papers, briefing notes, etc) on our website - Writing and publishing blogs, articles, and podcasts - Organizing events with both EUCOPE members and external stakeholders - Dissemination of EUCOPE messages through social media, external newsletters, and traditional media sources

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Kangaroo group European Policy Centre Healthcare Chain Institute

Organisation Members

http://www.eucope.org/en/eucope-members/

Connected Legislation